NASDAQ:EVLO

Evelo Biosciences, Inc.

Stock

USD

Market Cap

1.90K

Beta: 1.26

Volume Today

2.55K

Avg: 3.76M

PE Ratio

−0.01

PFCF: −0.01

Overview Financials Filings people Ownership API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22
net income	-13.33M -	-28.05M 110.37%	-56.95M 103.04%	-85.47M 50.09%	-93.67M 9.59%	-122.18M 30.44%	-114.53M 6.26%
depreciation and amortization	495K -	834K 68.48%	1.94M 132.01%	1.76M 8.84%	2.03M 14.85%	2.22M 9.38%	2.06M 7.04%
deferred income tax	20K -	301K 1,405%	406K 34.88%	-166K 140.89%	-6K 96.39%	3.22M 53,750%
stock based compensation	419K -	1.54M 268.02%	6.06M 292.93%	8.16M 34.76%	8.47M 3.71%	15.85M 87.13%	15.16M 4.34%
change in working capital	56K -	2.07M 3,596.43%	1.16M 43.77%	3.47M 198.45%	7.76M 123.52%	2.07M 73.37%	-9.67M 567.41%
accounts receivables
inventory
accounts payables	-43K -	774K 1,900%	-221K 128.55%	-585K 164.71%	837K 243.08%	159K 81.00%	170K 6.92%
other working capital	99K -	1.30M 1,209.09%	1.39M 6.87%	4.06M 193.07%	6.93M 70.68%	1.91M 72.45%	-9.84M 615.24%
other non cash items	28K -	35K 25%	103K 194.29%	255K 147.57%	2.35M 821.57%	2.10M 10.55%	5.74M 173.07%
net cash provided by operating activities	-12.31M -	-23.27M 88.93%	-47.28M 103.22%	-71.98M 52.25%	-73.06M 1.50%	-96.72M 32.39%	-101.23M 4.66%
investments in property plant and equipment	-1.25M -	-1.74M 39.36%	-5.46M 213.55%	-3.03M 44.49%	-1.32M 56.43%	-1.52M 14.99%	-622K 59.05%
acquisitions net	10.49M -
purchases of investments			-136.09M -
sales maturities of investments			81.25M -	55M 32.31%
other investing activites	27K -		171K -	2K 98.83%	6K 200%	38K 533.33%
net cash used for investing activites	9.26M -	-1.74M 118.81%	-60.13M 3,351.66%	51.97M 186.43%	-1.31M 102.53%	-1.48M 12.62%	-622K 58.00%
debt repayment	-4M -			-15M -			-47.61M -
common stock issued			75.83M -		54.99M -	81.75M 48.65%	84.54M 3.42%
common stock repurchased
dividends paid
other financing activites	19.74M -	48.97M 148.03%	86.18M 76.00%	19.99M 76.80%	10.47M 47.62%	15.79M 50.79%	44.72M 183.24%
net cash used provided by financing activities	15.74M -	48.97M 211.06%	162.01M 230.86%	4.99M 96.92%	65.47M 1,211.40%	97.54M 49.00%	81.66M 16.29%
effect of forex changes on cash							-454K -
net change in cash	12.69M -	23.96M 88.80%	54.60M 127.90%	-15.02M 127.50%	-8.91M 40.65%	-666K 92.53%	-20.66M 3,001.50%
cash at beginning of period	3.10M -	15.79M 410.05%	39.75M 151.78%	94.35M 137.38%	79.33M 15.92%	70.42M 11.23%	69.75M 0.95%
cash at end of period	15.79M -	39.75M 151.78%	94.35M 137.38%	79.33M 15.92%	70.42M 11.23%	69.75M 0.95%	49.10M 29.61%
operating cash flow	-12.31M -	-23.27M 88.93%	-47.28M 103.22%	-71.98M 52.25%	-73.06M 1.50%	-96.72M 32.39%	-101.23M 4.66%
capital expenditure	-1.25M -	-1.74M 39.36%	-5.46M 213.55%	-3.03M 44.49%	-1.32M 56.43%	-1.52M 14.99%	-622K 59.05%
free cash flow	-13.56M -	-25.01M 84.36%	-52.74M 110.90%	-75.01M 42.23%	-74.38M 0.84%	-98.24M 32.08%	-101.86M 3.68%

All numbers in USD (except ratios and percentages)